Symbiomix  announced positive results from the second pivotal trial of lead product candidate SYM-1219 (secnidazole) for the treatment of ...

In  continuation of my update on  abemaciclib Eli Lilly and Company (NYSE: LLY)    announced the results from the MONARCH 1 Phase 2 stud...

Pfizer Inc.    announced encouraging new data from a Phase 1/2 study of lorlatinib, the proposed generic name for PF-06463922, Pfizer’s in...

Researchers are announcing that Victoza, a diabetes drug sold by Danish drug giant  Novo Nordisk  , prevents heart attacks, strokes and ca...

Any of the prescription weight-loss drugs on the market can help obese people shed pounds, although some seem more effective than others, ...

S ince then, they have been looking for ways to improve the immunotherapeutic activity of M. brumae through the design of different emulsi...

   T he humble avocado, shunned for years during the fat-free diet craze of the 1990s, may have finally hit its stride. No longer just f...

According to a handful of recent studies, okra may reduce symptoms of diabetes - a group of diseases that includes type 1 diabetes, type 2...

It is the first study demonstrating that the extract protects against oral cancer, with the results of human, animal and laboratory tests ...